QT prolongation in patients with Type 2 diabetes and microalbuminuria

Clinical Autonomic Research

Volumn 12, Issue 5, 2002, Pages 366-372

  Rutter, Martin K ^a   Viswanath, Sathyamurthy ^b   McComb, Janet M ^c   Kesteven, Patrick ^c   Marshall, Sally M ^d  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Coronary risk; Maximum QT; Microalbuminuria; QT dispersion; QT prolongation; Type 2 diabetes

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 7;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; QT INTERVAL; RISK FACTOR; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; ALBUMINURIA; BLOOD; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED;

EID: 0036460277     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10286-002-0036-8     Document Type: Article

References (46)

1. Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Int Med 157: 1413-1418
2. c interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest 60: 323-332
3. Sawicki PT, Kiwitt S, Bender R, Berger M (1998) The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Int Med 243: 49-56
4. c dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: Cohort study. Br Med J 316: 745-746
5. Sawicki PT, Dahne R, Bender R, Berger M (1996) Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 39: 77-81
6. Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P (2000) QT interval prolongation and mortality in Type 1 diabetic patients: A 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care 23: 1381-1383
7. c interval predicts mortality in patients with Type 1 diabetes mellitus. Diabetic Med 18: 199-205
8. Elming H, Holm E, Jun L, Torp-Pedersen C, Kober L, Kircshoff M, et al. (1998) The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19: 1391-1400
9. c interval. Int J Cardiol 76: 75-80
10. Veglio M, Borra M, Stevens LK, Fuller JH, Perrin PC (1999) The relation between QTc interval prolongation and diabetic complications. The EURO-DIAB IDDM Complication Study Group. Diabetologia 42: 68-75
11. Festa A, D'Agostino R Jr, Rautaharju P, Mykkanen L, Haffner SM (2000) Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and Type 2 diabetic subjects. Am J Cardiol 86: 1117-1122
12. Carella MJ, Mantz SL, Rovner DR, Willis PWr, Gossain VV, Bouknight RR, et al. (1996) Obesity, adiposity, and lengthening of the QT interval: Improvement after weight loss. Int J Obes Relat Metab Disord 20: 938-942
13. c duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 45: 376-380
14. c in the diagnosis of autonomic failure among patients with diabetes: A meta-analysis. Diabetes Care 23: 241-247
15. Earle KA, Mishra B, Morocutti A, Barnes D, Chambers J, Viberti GC (2000) QT dispersion in microalbuminuric Type 1 diabetic patients without myocardial ischemia. J Diabet Complications 14: 277-280
16. c interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term Type 1 diabetes mellitus. J Diabet Complications 14: 90-95
17. Rutter MK, McComb JM, Brady S, Marshall SM (1999) Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol 83: 27-31
18. MacLeod JM, Lutale J, Marshall SM (1995) Albumin excretion and vascular deaths in NIDDM. Diabetologia 38: 610-616
19. Cowan JC, Yusoff K, Moore M, Amos PA, Gold AE, Bourke JP, et al. (1988) Importance of lead selection in QT interval measurement. Am J Cardiol 61: 83-87
20. Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7: 353-370
21. Hnatkova K, Malik M, Kautzner J, Gang Y, Camm AJ (1994) Adjustment of QT dispersion assessed from 12 lead electrocardiograms for different numbers of analysed electrocardiographic leads: Comparison of stability of different methods. Br Heart J 72: 390-396
22. Rutter MK, McComb JM, Brady S, Marshall SM (1998) Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria. Clin Auton Res 8: 251-257
23. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al. (1992) Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260
24. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419
26. Reardon M, Malik M (1996) QT interval change with age in an overtly healthy older population. Clin Cardiol 19: 949-952
27. Larsen JA, Kadish AH (1998) Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol 9: 655-664
28. Mitchell TH, Nolan B, Henry M, Cronin C, Baker H, Greely G (1997) Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure. Am J Med 102: 531-535
29. Nielsen FS, Ali S, Rossing P, Bang LE, Svendsen TL, Gall MA, et al. (1997) Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy. Diabetic Med 14: 538-546
30. Murray A, McLaughlin NB, Bourke JP, Doig JC, Furniss SS, Campbell RW (1994) Errors in manual measurement of QT intervals. Br Heart J 71: 386-390
31. Umetani K, Komori S, Ishihara T, Sawanobori T, Kohno I, Ijiri H, et al. (1999) Relation between QT interval dispersion and heart rate. Am J Cardiol 84: 1135-1137, A11
32. Zabel M, Franz MR, Klingenheben T, Mansion B, Schultheiss HP, Hohnloser SH (2000) Rate-dependence of QT dispersion and the QT interval: Comparison of atrial pacing and exercise testing. J Am Coll Cardiol 36: 1654-1658
33. Towbin JA, Vatta M (2001) Molecular biology and the prolonged QT syndromes. Am J Med 110: 385-398
34. Arildsen H, May O, Christiansen EH, Damsgaard EM (1999) Increased QT dispersion in patients with insulin-dependent diabetes mellitus. Int J Cardiol 71: 235-242
35. Clarkson PB, Naas AA, McMahon A, MacLeod C, Struthers AD, MacDonald TM (1995) QT dispersion in essential hypertension. Q J Med 88: 327-332
36. Kohler HP, Carter AM, Stickland MH, Grant PJ (1998) Levels of activated FXII in survivors of myocardial infarction-association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 79: 14-18
37. Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP (1997) Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol 17: 2103-2106
38. Sawicki PT (1996) Mortality in diabetic nephropathy: The importance of the QT interval. Nephrol Dial Transplant 11: 1514-1515
39. Glancy JM, Garratt CJ, de Bono DP (1996) Dynamics of QT dispersion during myocardial infarction and ischaemia. Int J Cardiol 57: 55-60
40. Ferrannini E, Galvan AQ, Gastaldelli A, Camastra S, Sironi AM, Toschi E, et al. (1999) Insulin: New roles for an ancient hormone. Eur J Clin Invest 29: 842-852
41. Lind L, Hvarfner A, Pollare T, Lithell H, Ljunghall S (1992) Fasting insulin, calcium metabolism and the electrocardiogram in hypertensive subjects. J Int Med 232: 335-339
42. Ziegler D, Laude D, Akila F, Elghozi JL (2001) Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res 11: 369-376
43. Puljevic D, Smalcelj A, Durakovic Z, Goldner V (1997) The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction. Int J Clin Pharmacol Ther 35: 381-384
44. Stramba-Badiale M, Goulene K, Schwartz PJ (1997) Effects of beta-adrenergic blockade on dispersion of ventricular repolarization in newborn infants with prolonged QT interval. Am Heart J 134: 406-410
45. Glancy JM, Weston PJ, Bhullar HK, Garratt CJ, Woods KL, de Bono DP (1996) Reproducibility and automatic measurement of QT dispersion. Eur Heart J 17: 1035-1039
46. Jermendy G, Koltai MZ, Pogatsa G (1990) QT interval prolongation in Type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathy. Acta Diabet Latina 27: 295-301